1. Nace, Lynn

Article Content

In a field as fast-paced as cancer research and care, it's hard to keep up with the sheer volume of information that comes your way, particularly when you have a plethora of print and online resources from which to choose. We're giving you one more reason why Oncology Times should be your "go-to." In your next issue (the Sept. 20, 2018 edition), you'll receive an exciting, innovative supplement like none other: HemOnc Times.

HemOnc Times. HemOnc... - Click to enlarge in new windowHemOnc Times. HemOnc Times

I know what you're thinking..."Another publication? I don't have time to read the ones I already receive!" You'll want to make time for this one. Why? Because we've partnered with the movers and shakers of the hematology/oncology field-Naveen Pemmaraju, MD; Pamela Crilley, DO; David Alan Rizzieri, MD, to name just a few-to not only deliver the most timely, relevant information, news, and updates, but we take it one step further by providing the "story behind the story."


Do you know, for example, why the esteemed Steven A. Rosenberg, MD, PhD, Chief, Surgery Branch, NCI, known for "pioneering the development of effective immunotherapies and gene therapies for patients with advanced cancers" pursued medicine?


Or why the initial CAR T-cell trial led by Carl H. June, MD, Director of Translational Research at the Abramson Cancer Center at the University of Pennsylvania, Philadelphia, was cut short, despite it being described as "nothing short of a miracle wrapped in science?"


Or what failures led to ultimate breakthroughs in CAR T-cell therapy, headed by Stephen Schuster, MD, also of University of Pennsylvania's Abramson Cancer Center?


You will after reading your first issue of HemOnc Times, which features in-depth interviews with these renowned individuals and their monumental impact on the treatment of cancer.


And while you're awaiting your print copy, I encourage you to visit our website,, (found under the "Articles and Issues" tab of Oncology Times), which is updated frequently with need-to-know news/updates and engaging multimedia. We'll keep you informed of updates with weekly eNewsletters, so be sure to sign up to receive them.


And to further emphasize our dedication and commitment to being your go-to resource for all things oncology and hematology/oncology, I invite you to register for our free webinar, "CAR T-Cell Breakthrough: An Interview with Dr. Stephen Schuster" on Sept. 18 at 7 pm ET. It's sure to be a captivating dialogue you won't want to miss.


We thank you for reading Oncology Times-and now its supplement, HemOnc Times-and look forward to bringing you the "story behind the story" in an engaging, distinctive new format.


Lynn Nace is Publisher of Oncology Times.

Lynn Nace. Lynn Nace... - Click to enlarge in new windowLynn Nace. Lynn Nace